Look above and you'll see that Pfizer and Novartis pharmaceutical are getting involved in the research area...seems Eli Lilly is also involved, at some level, with getting the drug currently in the pipeline, to be approved for sale. Seems some of the trials for their drug didn't show enough benefits to those with a certain stage of Alzheimer's disease. This doesn't mean that they're gonna scrap the whole plan, but means there are other pharm companies getting involved in order to "perfect" the drug, to make it better, so the best product evolves from this process...we wait with baited breath...
